Cite Filings / MAZE
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0001842295

  • Non-accelerated filer
  • Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-850-5070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Filings Financials Insiders Search text
All 225 Financials 25 Shareholder Meetings 1 Executive Compensation 20 Insider Trading 108 Beneficial Ownership Interest 26 Business Combinations 17 Public Offerings 19 Mutual Funds and ETFs 1 Others 47
›
Filed in
  1. No filings match these filters. Clear filters
  2. 3 Insider Initial Statement of Ownership 2025-01-30
  3. 3 Insider Initial Statement of Ownership 2025-01-30
  4. 3 Insider Initial Statement of Ownership 2025-01-30
  5. 3 Insider Initial Statement of Ownership 2025-01-30
  6. 3 Insider Initial Statement of Ownership 2025-01-30
  7. 3 Insider Initial Statement of Ownership 2025-01-30
  8. 3 Insider Initial Statement of Ownership 2025-01-30
  9. 3 Insider Initial Statement of Ownership 2025-01-30

Page 6 of 6 · 108 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…